Page 1 of Clinical Trials for Hypolipidemic Agents, 1683 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs
Last Updated: March 1, 2012
Condition(s): HIV Infection
2
Completed
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
Last Updated: September 22, 2010
Condition(s): Cardiovascular Disease
3
Completed
National Survey on Dyslipidemic Patients
Last Updated: August 4, 2009
Condition(s): Dyslipidemia
4
Completed
Safety of a Hypolipidemic Agent in Healthy Normal Volunteers
Last Updated: June 25, 2008
Condition(s): Hyperlipidemia
5
Completed
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
Last Updated: May 17, 2012
Condition(s): HIV Infections
6
Completed
Antihyperlipidemic Effects of Oyster Mushrooms
Last Updated: September 25, 2007
Condition(s): HIV Infections; Hyperlipidemia
7
Completed
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
Last Updated: July 9, 2008
Condition(s): Cardiovascular Diseases
8
Completed
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)(COMPLETED)
Last Updated: April 15, 2010
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
9
Completed
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)(COMPLETED)
Last Updated: April 15, 2010
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
10
Completed
Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India
Last Updated: March 20, 2012
Condition(s): Dyslipidemia; Type 2 Diabetes Mellitus
11
Completed
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea
Last Updated: December 21, 2011
Condition(s): Dyslipidemia
12
Completed
Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Last Updated: March 13, 2009
Condition(s): Hypercholesterolemia
13
Completed
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
Last Updated: April 14, 2010
Condition(s): Prediabetes; Hypercholesterolemia; Inflammation; Cardiovascular Risk
14
Completed
A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers
Last Updated: November 25, 2009
Condition(s): HIV
15
Completed
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Last Updated: December 14, 2009
Condition(s): Healthy
16
Completed
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Last Updated: March 13, 2006
Condition(s): HIV Infections; HIV Seronegativity; Lipodystrophy
17
Completed
Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
Last Updated: August 16, 2011
Condition(s): Hyperlipidemia
18
Recruiting
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
Last Updated: June 30, 2011
Condition(s): ST-Segment Elevation Myocardial Infarction
19
Recruiting
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Last Updated: March 16, 2012
Condition(s): Cardiovascular Diseases
20
Enrolling by invitation
Tailored Communication to Reduce Cardiovascular Risk
Last Updated: September 14, 2011
Condition(s): Hypercholesterolemia; Coronary Artery Disease; Dyslipidemia; Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Hypolipidemic+Agents

Page 1 of Clinical Trials for Hypolipidemic Agents, 1683 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About